## Abstract A __post hoc__ analysis of the SPECTRUM trial was carried out to evaluate whether the improvements in efficacy and tolerability gained on switching to quetiapine occurred consistently for patients previously treated with either: haloperidol (__n__β=β43); olanzapine (__n__β=β66); or risp
β¦ LIBER β¦
Efficacy and tolerability of quetiapine in poorly responsive, chronic schizophrenia
β Scribed by Peter F. Buckley; Jeffrey M. Goldstein; Robin A. Emsley
- Book ID
- 119362059
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 259 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0920-9964
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Efficacy and tolerability of quetiapine
β
Ilkka Larmo; AndrΓ© de Nayer; Elmar Windhager; Irmansyah; Bernhard Lindenbauer; H
π
Article
π
2005
π
John Wiley and Sons
π
English
β 103 KB
π 2 views
A comparison of the relative safety, eff
β
Jamie Mullen; Michael D Jibson; Dennis Sweitzer
π
Article
π
2001
π
Elsevier Science
π
English
β 727 KB
Quetiapine has equivalent efficacy and s
β
M. Riedel; N. MΓΌller; M. Strassnig; I. Spellmann; R. R. Engel; R. Musil; S. Dehn
π
Article
π
2005
π
Springer-Verlag
π
English
β 264 KB
Efficacy and tolerability of aripiprazol
β
A. Forbes; M. Nyilas; J. Loze; C. Werner; B. Johnson; R. Owen; S. Todorov; W.H.
π
Article
π
2008
π
Elsevier Science
π
French
β 47 KB
Efficacy and tolerability of quetiapine
β
G. Cerveri; L.S. Volonteri; I. Netti; C. Mencacci
π
Article
π
2008
π
Elsevier Science
π
French
β 44 KB
Efficacy and safety of quetiapine for de
β
Kyoung-Uk Lee; Yang-Whan Jeon; Hae-Kook Lee; Tae-Youn Jun
π
Article
π
2009
π
John Wiley and Sons
π
English
β 121 KB
π 2 views
## Objective: To investigate the efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia. ## Method: Thirty-nine patients fulfilling dsm-iv-tr diagnostic criteria for schizophrenia and had depressive symptoms were studied in a prospective 6-week open-label design